In the BioHarmony Drug Report Database

"Preview" Icon

Adapalene

Differin (adapalene) is a small molecule pharmaceutical. Adapalene was first approved as Differin on 1996-05-31. It is used to treat acne vulgaris in the USA. The pharmaceutical is active against retinoic acid receptor beta and retinoic acid receptor gamma. In addition, it is known to target retinoic acid receptor alpha. Epiduo’s patents are valid until 2028-05-31 (FDA).

 

Trade Name

 

Differin
 

Common Name

 

adapalene
 

ChEMBL ID

 

CHEMBL1265
 

Indication

 

acne vulgaris
 

Drug Class

 

Retinoids

Image (chem structure or protein)

Adapalene structure rendering